SR

Shailesh Ramnathji Jaiswal

Active Director Director DIN 07111713
DIN 07111713 First appointment Jun 2015 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Shailesh Ramnathji Jaiswal

Data last updated:

Shailesh Ramnathji Jaiswal is a Director at Nisha Superspeciality Hospital Private Limited (since 2015). The company operates in Healthcare.

DIN 07111713
Primary Designation Director
Industry Healthcare
First Appointment 15 Jun 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jun 20152015Active

Board colleagues of Shailesh Ramnathji Jaiswal

Directorship timeline

Open interactive timeline →
Nisha Superspeciality Hospital Private Limited
Premium access

Shareholding and investment profile for Shailesh Ramnathji Jaiswal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailesh Ramnathji Jaiswal

Shailesh Ramnathji Jaiswal currently holds 1 directorship: Nisha Superspeciality Hospital Private Limited (Director, since 15 Jun 2015).

Shailesh Ramnathji Jaiswal was first appointed on 15 Jun 2015 as Director at Nisha Superspeciality Hospital Private Limited.

The current boards of Shailesh Ramnathji Jaiswal's companies include Nowmani Samdani Shaikh (Nisha Superspeciality Hospital Private Limited), Shabana Yawarali Khan (Nisha Superspeciality Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available